Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada

OBJECTIVES: Primary Objective: To determine if pre-exposure prophylaxis (PrEP) with 400mg hydroxychloroquine (HCQ), taken orally once daily reduces microbiologically confirmed COVID-19 among front line health care workers at high risk for SARS-CoV-2 exposure. Secondary Objectives: To compare the fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Julie K., Tan, Darrell H. S., Walmsley, Sharon L., Hulme, Jennifer, O’Connor, Erin, Snider, Carolyn, Cheng, Ivy, Chan, Adrienne K., Borgundvaag, Bjug, McLeod, Shelley, Gollob, Michael H., Clarke, Rosemarie J., Dresser, Linda, Haji, Fatima, Mazzulli, Tony, Mubareka, Samira, Jüni, Peter, Lee, Dominic, Tomlinson, George, Kain, Kevin C., Landes, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359423/
https://www.ncbi.nlm.nih.gov/pubmed/32665039
http://dx.doi.org/10.1186/s13063-020-04577-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359423/
https://www.ncbi.nlm.nih.gov/pubmed/32665039
http://dx.doi.org/10.1186/s13063-020-04577-8

Ejemplares similares